Stakeholders Urge Collaborative Efforts to Improve Cancer Care

Healthcare stakeholders have urged urgent collaboration to close the widening gap in cancer treatment across the country.

During a high‑level Executive Business Networking Dinner in Lagos, leaders from healthcare, policy, investment, finance and hospital administration called for joint action to tackle the crisis in cancer care in Nigeria.

They highlighted critical infrastructure deficits as a major threat to healthcare delivery nationwide, warning that immediate investment and stronger partnerships are essential to stem the growing cancer care gap and poor infrastructure.

The event was organized by global healthcare technology firm SHINVA Medical Solutions and Hospital Assist Nigeria (HAN), which announced new plans to support oncology expansion, infection prevention and hospital modernization throughout Nigeria.

Hospital Assist Nigeria CEO Dr. Wale Alabi described the SHINVA‑HAN collaboration as a strategic platform aimed at delivering world‑class healthcare technologies while bolstering local technical capacity and sustainable health systems.

He said the partnership extends beyond medical equipment deployment to include training, maintenance support and long‑term infrastructure development.

“The collaboration is designed to improve cancer care, infection prevention, hospital operations and overall healthcare outcomes across Nigeria,” Alabi stated.

He added that building local technical expertise and sustainable maintenance structures will be crucial for ensuring the long‑term functionality of advanced technologies introduced into Nigerian hospitals.

Highlighting SHINVA’s global reach, Africa Business Network Representative Mr. Kelvin Chen said Nigeria remains one of Africa’s most strategic healthcare markets.

He noted SHINVA’s expanding footprint across Africa and other international markets, showcasing the company’s portfolio in oncology, radiotherapy, medical imaging, pharmaceutical equipment, sterilisation systems and healthcare infrastructure solutions.

Chen emphasized SHINVA’s Linear Accelerators and industrial sterilisation technologies as critical tools for strengthening cancer treatment and infection prevention capacity in Nigeria.

“We are committed to long‑term partnerships in Nigeria and ready to collaborate with healthcare providers, governments, investors and development institutions to support healthcare transformation,” he said.

Healthcare Federation of Nigeria President Ms. Njide Ndili acknowledged the growing role of the private sector in healthcare delivery and investment in the country.

She urged SHINVA and HAN to ensure that innovative technologies remain accessible, affordable, scalable and sustainable for Nigerians.

“Healthcare innovation must not only be advanced but also accessible and sustainable if we truly want to improve healthcare outcomes in Nigeria,” Ndili said.

Oncology and healthcare investment strategist Mr. Fisayo Okunsanya, speaking on Nigeria’s oncology landscape, painted a grim picture of the country’s cancer treatment infrastructure, noting that existing facilities remain grossly inadequate for the rising number of patients.

Okunsanya identified major investment opportunities in the sector but stressed that sustainable progress would require stronger private‑sector participation, innovative financing models and supportive government policies.

“There is a significant gap between cancer treatment demand and existing infrastructure in Nigeria. This presents both a healthcare challenge and a major investment opportunity,” he stated.

The event drew several top healthcare leaders and decision‑makers, including Chief Medical Director of Redeemer’s Health Village Dr. Adedamola Dada; Founder and Chairman of Reddington Hospital Group Dr. Adeyemi Onabowale; former President of AGPMPN Dr. Anthony Omolola; Chief Medical Officer of Marcelle Ruth Cancer Centre Dr. Misbah Oleolo; Chidinma Chigbo Anachebe of FCMB; Dr. Samuel Keshinro of the Nigerian Police Hospital; Dr. Voke Toye of Biologix Laboratories; Prof. Adebowale Adekoya of LASUTH; Dr. Akinbiyi Oke of Avon Medical Practice; Dr. Babatunde Olujobi, CEO of Donolush Nigeria Ltd.; Iquomma Uboh of HFN; and Luke Wang of ShinvaChina, among other stakeholders.

Discussions focused on healthcare innovation, strategic partnerships, investment opportunities, hospital modernization, pharmaceutical manufacturing and expanding access to advanced technologies.

The session was moderated by Pacific Messages Executive Project Director Moses Braimah, who guided talks on investment opportunities and collaborative strategies for strengthening Nigeria’s healthcare system.

Participants agreed that stronger collaboration among technology providers, healthcare institutions, investors and government agencies is crucial to addressing Nigeria’s infrastructure gaps, particularly in oncology, infection control, hospital modernization and pharmaceutical manufacturing.

Stakeholders expressed optimism that the networking dinner would spark new partnerships, investments and infrastructure projects capable of strengthening healthcare delivery across the country.